About JDI Pacific
JDI Pacific makes machines that separate selected cells for university laboratories and biotechnology startups. The benchtop instruments use a proprietary chip to reduce pressure, cost and operating complexity.
The company is based in the San Francisco Bay Area. Songtao Ye is chief executive officer, and Hany Nassef is an executive officer.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Apr 30, 2026 | Nov 16, 2026amended Nov 17, 2026 | $500,000fully sold | 1 | $500K | SAFE (Simple Agreement for Future Equity)Rule 506(b) | Form D/A ↗1 earlier filing |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on JDI Pacific's Form D filed Nov 17, 2026.
Why Investors Backed JDI Pacific
Traditional cell sorting can require a six-figure budget and complex droplet and high-voltage methods. The investment case centers on lowering those barriers while keeping cells viable. [1]
Origin and Team
The founding team brings experience in cell sorting, optical engineering and instrument manufacturing. [1]
Product and Technology
The sorter operates below 1 psi, more than 20 times gentler than traditional systems. Its lower pressure is designed to keep cells viable. [1]
A proprietary chip handles sorting without droplet generation or high-voltage deflection. The benchtop unit costs a fraction of legacy sorters. [1]
We wrote this summary from public statements by JDI Pacific and its investors. It is not investment advice.
Sources
- CompanyJDI Pacific website · linked above ↑
- SECJDI Pacific Form D, filed 2026-11-16
- SECJDI Pacific Form D/A, filed 2026-11-17 · linked above ↑
- SECJDI Pacific filing history